Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III ...

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for the combination regimen of VENCLEXTA® (venetoclax) and ...

Commercial adoption of the Galleri multi-cancer early detection test remained a bright spot, with more than 185,000 tests ...

Sandoz and Polpharma Biologics have become the first companies to get FDA approval for a biosimilar of Biogen's blockbuster multiple sclerosis therapy Tysabri, after overcoming a bid by Biogen to ...

Key opportunities in the pancreatic cancer market include advancing novel therapies such as masitinib, pamrevlumab, and quemliclustat, alongside strategic collaborations and FDA designations to foster ...

As with randomization, if allocation to the study drug is not carried out in accordance with the protocol, the entire study ...

Investing.com -- Evommune Inc. (NYSE:EVMN) stock soared 64% after the clinical-stage biotechnology company announced positive top-line results from its Phase 2a trial evaluating EVO301 in patients ...

Diabetes drug metformin may reduce the risk of a serious eye disease (macular degeneration) by 37%, helping diabetes patients ...

Solvej Balle, trans. from the Danish by Jennifer Russell and Sophia Hersi Smith. New Directions, $15.95 trade paper (176p) ISBN 978-0-8112-3841-0 Balle picks up her remarkable seven-part saga of a ...

Side effects of IV drips for skin: IV drips can lead to certain side effects, like vein inflammation, infections from the treatment, allergic reactions, and even complications if the body rejects the ...

When enhanced CT images are used for dose calculation, the increased electron density of tissues must be accounted for to avoid dose biases (9). While previous studies have demonstrated statistically ...

Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling. Performing calculations for the formulation of pharmaceutical dosage forms and ...